Cargando…

Analysis of AKT and ERK1/2 protein kinases in extracellular vesicles isolated from blood of patients with cancer

BACKGROUND: Extracellular vesicles (EVs) are small nanometre-sized vesicles that are circulating in blood. They are released by multiple cells, including tumour cells. We hypothesized that circulating EVs contain protein kinases that may be assessed as biomarkers during treatment with tyrosine kinas...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Mijn, Johannes C., Sol, Nik, Mellema, Wouter, Jimenez, Connie R., Piersma, Sander R., Dekker, Henk, Schutte, Lisette M., Smit, Egbert F., Broxterman, Henk J., Skog, Johan, Tannous, Bakhos A., Wurdinger, Thomas, Verheul, Henk M. W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Co-Action Publishing 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261239/ https://www.ncbi.nlm.nih.gov/pubmed/25491250 http://dx.doi.org/10.3402/jev.v3.25657

Ejemplares similares

Evaluation of a tyrosine kinase peptide microarray for tyrosine kinase inhibitor therapy selection in cancer
por: Labots, Mariette, et al.
Publicado: (2016)

Effects of Cancer Presence and Therapy on the Platelet Proteome
por: Walraven, Maudy, et al.
Publicado: (2021)

Peptide-mediated ‘miniprep’ isolation of extracellular vesicles is suitable for high-throughput proteomics
por: Knol, Jaco C., et al.
Publicado: (2016)

RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics
por: Best, Myron G., et al.
Publicado: (2015)

Cross-resistance to clinically used tyrosine kinase inhibitors sunitinib, sorafenib and pazopanib
por: Gotink, Kristy J., et al.
Publicado: (2015)

Acquired tumor cell resistance to sunitinib causes resistance in a HT-29 human colon cancer xenograft mouse model without affecting sunitinib biodistribution or the tumor microvasculature
por: Gotink, Kristy J., et al.
Publicado: (2014)

Kinase Inhibitor Treatment of Patients with Advanced Cancer Results in High Tumor Drug Concentrations and in Specific Alterations of the Tumor Phosphoproteome
por: Labots, Mariette, et al.
Publicado: (2020)

Advancing wide implementation of precision oncology: A liquid nitrogen‐free snap freezer preserves molecular profiles of biological samples
por: van der Wijngaart, Hanneke, et al.
Publicado: (2023)

Heparin affinity purification of extracellular vesicles
por: Balaj, Leonora, et al.
Publicado: (2015)

Novel drugs that target the metabolic reprogramming in renal cell cancer
por: van der Mijn, Johannes C., et al.
Publicado: (2016)

Selection of Protein Kinase Inhibitors Based on Tumor Tissue Kinase Activity Profiles in Patients with Refractory Solid Malignancies: An Interventional Molecular Profiling Study
por: Labots, Mariette, et al.
Publicado: (2018)

Proteomic Analysis of miR-195 and miR-497 Replacement Reveals Potential Candidates that Increase Sensitivity to Oxaliplatin in MSI/P53wt Colorectal Cancer Cells
por: Poel, Dennis, et al.
Publicado: (2019)

Patient-Derived Glioma Models: From Patients to Dish to Animals
por: da Hora, Cintia Carla, et al.
Publicado: (2019)

Platelet RNA signatures for the detection of cancer
por: Sol, Nik, et al.
Publicado: (2017)

Candidate biomarkers for treatment benefit from sunitinib in patients with advanced renal cell carcinoma using mass spectrometry-based (phospho)proteomics
por: van der Wijngaart, Hanneke, et al.
Publicado: (2023)

A functional bioassay to determine the activity of anti-VEGF antibody therapy in blood of patients with cancer
por: Wentink, Madelon Q, et al.
Publicado: (2016)

Tumor Drug Concentration and Phosphoproteomic Profiles After Two Weeks of Treatment With Sunitinib in Patients with Newly Diagnosed Glioblastoma
por: van Linde, Myra E., et al.
Publicado: (2022)

Hypoxia Impairs Initial Outgrowth of Endothelial Colony Forming Cells and Reduces Their Proliferative and Sprouting Potential
por: Tasev, Dimitar, et al.
Publicado: (2018)

Epithelial Transfer of the Tyrosine Kinase Inhibitors Erlotinib, Gefitinib, Afatinib, Crizotinib, Sorafenib, Sunitinib, and Dasatinib: Implications for Clinical Resistance
por: Honeywell, Richard J., et al.
Publicado: (2020)

Pulsatile high-dose treatment with antiangiogenic tyrosine kinase inhibitors improves clinical antitumor activity
por: Rovithi, Maria, et al.
Publicado: (2017)

Blood platelet RNA enables the detection of multiple sclerosis
por: Sol, Nik, et al.
Publicado: (2020)

Functional multiplex reporter assay using tagged Gaussia luciferase
por: van Rijn, Sjoerd, et al.
Publicado: (2013)

Longitudinal stability of urinary extracellular vesicle protein patterns within and between individuals
por: Erozenci, Leyla A., et al.
Publicado: (2021)

Constitutively active GSK3β as a means to bolster dendritic cell functionality in the face of tumour-mediated immune suppression
por: López González, Marta, et al.
Publicado: (2019)

Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?
por: Gotink, Kristy J., et al.
Publicado: (2009)

In vivo tomographic imaging of red-shifted fluorescent proteins
por: Deliolanis, Nikolaos C., et al.
Publicado: (2011)

Between Protest and Counter-Expertise: User Knowledge, Activism, and the Making of Urban Cycling Networks in the Netherlands Since the 1970s
por: Dekker, Henk-Jan
Publicado: (2022)

Evaluation of potential circulating biomarkers for prediction of response to chemoradiation in patients with glioblastoma
por: van Linde, Myra E., et al.
Publicado: (2016)

Development of bioluminescent chick chorioallantoic membrane (CAM) models for primary pancreatic cancer cells: a platform for drug testing
por: Rovithi, Maria, et al.
Publicado: (2017)

Time dependent effect of cold ischemia on the phosphoproteome and protein kinase activity in fresh-frozen colorectal cancer tissue obtained from patients
por: Buffart, Tineke E., et al.
Publicado: (2021)

Predictors for use of psychosocial services in patients with metastatic colorectal cancer receiving first line systemic treatment
por: Schuurhuizen, Claudia S. E. W., et al.
Publicado: (2019)

The Potential Role of Lysosomal Sequestration in Sunitinib Resistance of Renal Cell Cancer
por: Azijli, Kaamar, et al.
Publicado: (2015)

The Potential Application of Extracellular Vesicles from Liquid Biopsies for Determination of Pharmacogene Expression
por: Habtemariam, Henok D., et al.
Publicado: (2022)

BSCI-04. Tumor-educated platelets promote breast cancer brain metastasis and therapeutic resistance
por: Tabet, Elie, et al.
Publicado: (2021)

Visualization and tracking of tumour extracellular vesicle delivery and RNA translation using multiplexed reporters
por: Lai, Charles P., et al.
Publicado: (2015)

INKA, an integrative data analysis pipeline for phosphoproteomic inference of active kinases
por: Beekhof, Robin, et al.
Publicado: (2019)

Blood platelets as an RNA biomarker platform for neuro-oncological diseases
por: Post, Edward, et al.
Publicado: (2022)

A specific microRNA profile as predictive biomarker for systemic treatment in patients with metastatic colorectal cancer
por: Poel, Dennis, et al.
Publicado: (2020)

Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancer
por: Nilsson, R. Jonas A., et al.
Publicado: (2015)

Effects of Peri-Conception and Pregnancy Glycemic Variability on Pregnancy and Perinatal Complications in Type 1 Diabetes: A Pilot Study
por: Hoek-Hogchem, Riëlle, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dmvujr762v1ggp8ll34fkuki3o